GTC

Ghost Tree Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200,000	Closed	-$1.41M	–	60
2023 Q2	$1.41M	Sell	200,000 -75,000	-27%	-$528K	0.46%	42
2023 Q1	$2.29M	Buy	275,000 +50,000	+22%	+$417K	0.68%	34
2022 Q4	$2.58M	Sell	225,000 -300,000	-57%	-$3.44M	1.1%	25
2022 Q3	$6.62M	Buy	525,000 +200,000	+62%	+$2.52M	1.86%	16
2022 Q2	$3.44M	Sell	325,000 -25,000	-7%	-$265K	1.79%	21
2022 Q1	$5.69M	Buy	+350,000	New	+$5.69M	1.24%	15
2021 Q2	–	Sell	-500,000	Closed	-$5.09M	–	53
2021 Q1	$5.09M	Sell	500,000 -400,000	-44%	-$4.07M	1.2%	26
2020 Q4	$6.71M	Sell	900,000 -1,050,000	-54%	-$7.82M	1.49%	23
2020 Q3	$6.7M	Buy	1,950,000 +50,000	+3%	+$172K	1.94%	17
2020 Q2	$9.05M	Sell	1,900,000 -100,000	-5%	-$477K	2.39%	14
2020 Q1	$4M	Sell	2,000,000 -1,000,000	-33%	-$2M	1.06%	17
2019 Q4	$10.4M	Buy	3,000,000 +1,500,000	+100%	+$5.18M	1.97%	15
2019 Q3	$4.3M	Sell	1,500,000 -1,000,000	-40%	-$2.87M	1.1%	25
2019 Q2	$9.48M	Buy	2,500,000 +2,000,000	+400%	+$7.58M	1.97%	11
2019 Q1	$4.07M	Hold	500,000	–	–	1.06%	30
2018 Q4	$4.04M	Hold	500,000	–	–	1.46%	22
2018 Q3	$3.82M	Buy	+500,000	New	+$3.82M	0.81%	30
2017 Q4	–	Sell	-500,000	Closed	-$2.62M	–	46
2017 Q3	$2.62M	Sell	500,000 -175,000	-26%	-$917K	0.56%	42
2017 Q2	$3.75M	Sell	675,000 -825,000	-55%	-$4.59M	0.78%	37
2017 Q1	$12.6M	Buy	1,500,000 +350,000	+30%	+$2.94M	2.35%	5
2016 Q4	$7.28M	Sell	1,150,000 -650,000	-36%	-$4.11M	1.75%	17
2016 Q3	$7.94M	Buy	1,800,000 +100,000	+6%	+$441K	1.29%	15
2016 Q2	$4.83M	Buy	+1,700,000	New	+$4.83M	1.39%	21
2015 Q4	–	Sell	-225,000	Closed	-$2.57M	–	50
2015 Q3	$2.57M	Buy	225,000 +180,000	+400%	+$2.05M	1.15%	34
2015 Q2	$672K	Buy	+45,000	New	+$672K	0.22%	57